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Abstract
Background: Magnetic nanoparticles have been significantly used for coupling with biomolecules,
due to their unique properties.
Methods: Magnetic nanoparticles were synthesized by thermal co-precipitation of ferric and
ferrous chloride using two different base solutions. Glucose oxidase was bound to the particles by
direct attachment via carbodiimide activation or by thiophene acetylation of magnetic
nanoparticles. Transmission electron microscopy was used to characterize the size and structure
of the particles while the binding of glucose oxidase to the particles was confirmed using Fourier
transform infrared spectroscopy.
Results: The direct binding of glucose oxidase via carbodiimide activity was found to be more
effective, resulting in bound enzyme efficiencies between 94–100% while thiophene acetylation was
66–72% efficient. Kinetic and stability studies showed that the enzyme activity was more preserved
upon binding onto the nanoparticles when subjected to thermal and various pH conditions. The
overall activity of glucose oxidase was improved when bound to magnetic nanoparticles
Conclusion: Binding of enzyme onto magnetic nanoparticles via carbodiimide activation is a very
efficient method for developing bioconjugates for biological applications
Background
The immobilization of biomolecules onto insoluble sup-
ports is an important tool for the fabrication of a diverse
range of functional materials or devices [1]. Enzyme
immobilization for example, is a desired biological proce-
dure because of the possible application of immobilized
enzymes in continuous operations, product purification,
and catalyst recycling [2]. Furthermore, immobilization
provides many advantages such as enhanced stability,
easy separation from reaction mixture, possible modula-
tion of the catalytic properties, and easier prevention of
microbial growth [3].
In the last decade, nanosize materials have been widely
used as support for this purpose. Among these materials,
magnetic nanoparticles are very popular when used in
conjunction with biological materials including proteins,
peptides, enzymes [4-9] antibodies and nucleic acids [8],
because of their unique properties [4-9]. The ability to
tract magnetically labeled entities or target organelles
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using magnetic force offer the opportunity to conduct bio-
logical operations with increased specificity.
Magnetite (Fe3O4) are biocompatible superparamagnetic
materials that have low toxicity and strong magnetic prop-
erties [5]. They have been widely used for in vivo exami-
nation including magnetic resonance imaging, contrast
enhancement, tissue specific release of therapeutic agents,
hyperthermia [10,11], magnetic field assisted radionucle-
ide therapy [11], as well as in vitro binding of proteins and
enzymes [4-8].
Magnetite nanoparticles have been used as support mate-
rial for binding of enzymes including yeast alcohol dehy-
drogenase [4] and lipase [5] directly via carbodiimide
activation. This method brought about considerable
promise because of its simplicity and efficiency. Recently,
γ -Fe2O3magnetic nanoparticles were used for binding
Candida rugosa lipase after acetylation of thiophene func-
tionalized nanoparticles, or through nitroso-derivative
formed on the surface of the particles by reacting nitroso
tetrafluoroborate in methylene chloride. Both methods
and more effectively lipase immobilized on acetylated
nanoparticles exhibited long term stability. Glucose oxi-
dase (GOX, β -D-glucose oxygen 1-oxidoreductase, EC
1.1.3.4) is a homodimer flavoprotein containing two
active sites per molecule [12,13]. It catalyses the oxidation
of  β -D-glucose to gluconic acid, concomitant with the
reduction of oxygen to hydrogen peroxide. Glucose oxi-
dase has been used to test various types of enzyme immo-
bilization, and is the most commonly studied in the
construction of biosensors for glucose assay development
[12,14,15]. A more recent study [16] examined the activity
of cholesterol oxidase activity using carbodiimide
activation.
Here, we report the stability and enzymatic activity of glu-
cose oxidase immobilized onto Fe3O4 magnetic nanopar-
ticles using two binding methods, the direct binding via
carbodiimide activation of amino functionalized particles
and binding to thiophene-functionalized acetylated nan-
oparticles. A comparison of the stability and activity of
glucose oxidase immobilized to magnetite using different
protocols will lay the foundation for magnetic immu-
noassays. The size and structure of the nanoparticles were
characterized using Transmission electron microscopy
(TEM) and Fourier Transform Infrared (FTIR) spectros-
copy, respectively. The stability, activity, and kinetic
behavior of bound glucose oxidase were also examined.
Materials and methods
Glucose oxidase (specific activity 200 units/mg protein)
from Aspergillus niger was purchased from VWR interna-
tional (Pittsburgh, USA). Carbodiimide-HCl (1-ethyl-3-
(3-dimethyl-aminopropyl), ammonium hydroxide,
sodium hydroxide, acetic anhydride, glucose, bovine
serum albumin (BSA), iron (II) chloride tetrahydrate 97
% and iron (III) chloride hexahydrate 99%, were obtained
from Sigma-Aldrich St Louis (USA). 11-bromoundecanoic
acid was obtained from TCI America Portland, USA. The
Biorad Protein Assay Reagent Concentrate was purchased
from Biorad Laboratories (Hercules, CA). Thiophene-2-
thiolate was obtained from Alfa Aesar MA, USA. Iodine
was obtained from Mallinckrodt Kentucky, USA, and ace-
tonitrile was obtained from EMD Chemicals (New Jersey,
USA). Sodium phosphate monohydrate and potassium
phosphate dihydrate were acquired from EM Science
(New Jersey, USA). Sodium carbonate was obtained from
Orion Research Inc. (Beverly, USA). Magnetic nanoparti-
cles (Fe3O4) were prepared by chemical co-precipitation
of Fe2+ and Fe3+ ions in a solution of ammonium hydrox-
ide (magnetic nanoparticles I or Fe3O4  I), or sodium
hydroxide (magnetic nanoparticles II or Fe3O4 II) fol-
lowed by a treatment under hydrothermal conditions
[4,5]. Iron (II) chloride and iron (III) chloride (1:2) were
dissolved in nanopure water at the concentration of 0.25
M iron ions and chemically precipitated at room temper-
ature (25°C) by adding NH4OH solution (30%) or
NaOH 3 M at a pH 10. The precipitates were heated at
80°C for 35 min under continuous mixing and washed 4
times in water and several times in ethanol. During wash-
ing, the magnetic nanoparticles were separated from the
supernatant using a magnetic separator of strength greater
than 20 megaoersted (MOe). The particles were finally
dried in a vacuum oven at 70°C. The dried particles exhib-
ited a strong magnetic attraction.
Magnetic nanoparticles I (50 mg) produced, using a solu-
tion of ammonium hydroxide were added to 1 mL of
phosphate buffer (0.05 M. pH 7.4). After adding 1 mL of
carbodiimide solution (0.02 g/mL) in phosphate buffer
(0.05 M. pH 7.4), the mixture was sonicated for 15 min.
Following the carbodiimide activation, 2 mL of glucose
oxidase (1000 units /mL) was added and the reaction mix-
ture was sonicated for 30 min at 4°C in a sonication bath.
The magnetic nanoparticles were separated from the mix-
ture using a magnetic separator. The precipitates contain-
ing Fe3O4  nanoparticles I and Fe3O4  bound glucose
oxidase (GOX-Fe3O4  I) were washed with phosphate
buffer pH 7.4 and 0.1 M Tris, pH 8.0, and then used for
activity and stability measurements. NaCl was added to
enhance the separation of the magnetic nanoparticles [4].
A second functionalization protocol using a modification
of the strategy adopted to immobilize Candida rugosa
lipase on the γ -Fe2O3[12] was implemented (Magnetic
nanoparticles II). Briefly, 1.5 g Fe3O4 was added to 5 g of
11-bromoundecanoic acid dissolved in 15 mL of ethanol.
11-bromoundecanoic acid was covalently linked to the
nanoparticles surfaces by heating the mixture withBioMagnetic Research and Technology 2005, 3:1 http://www.biomagres.com/content/3/1/1
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microwave irradiation for 10 min. Functionalization of
the particle was achieved through nucleophilic substitu-
tion with the 2-thiophene thiolate. In practice, 2-thi-
ophene thiolate (7 mL) was added to the mixture
containing the particles and heated in microwave for 5
minutes. The mixture was washed with ethanol and trans-
ferred in a round bottom flask. Acetic anhydride (4 mL)
and 34.6 mL of iodine (0.01N) were successively added to
the particles and agitated. The mixture was heated for 1 h
under reflux condition [17]. The particles were washed
several times with water, once with 10% sodium carbon-
ate solution and finally with ethanol. The acetylated par-
ticles were reacted directly with the enzyme covalently
linked to the particles via C = N bond [11].
For the attachment of glucose to nanoparticles, 2 mL of
the GOX solution (1000 units/mL) was added to 50 mg of
functionalized magnetic nanoparticles in a test tube and
sonicated at 15°C for 3 h. The supernatant containing
unbound enzymes was separated from the magnetic nan-
oparticles using the magnetic separator, and the enzymes
bound to magnetic nanoparticles were then used for activ-
ity determination. A schematic of the procedures used for
both attachments are presented in Figure 1. The amount
of protein in the supernatant was determined by a colori-
metric method at 595 nm with the Biorad Protein Assay
Reagent Concentrate using bovine serum albumin (BSA)
as the protein standard. The amount of bound enzymes
was calculated from:
A = (Ci - Cs)* V   (1)
Where A is the amount of bound enzyme, Ci and Cs are the
concentration of the enzyme initially added for attach-
ment and in the supernatant, respectively (mg/mL) and V
is the volume of the reaction medium (mL). The size of
Fe3O4 magnetic nanoparticles, GOX-Fe3O4 I and GOX-
Fe3O4  II were characterized by transmission electron
microscopy (TEM, JEM 1200 EXII, JEOL) and structure by
FTIR spectroscopy (Biorad FTS 6000, Cambridge, MA).
The samples for TEM analysis were prepared as follows: a
drop of magnetic nanoparticles was dispersed in nanop-
ure water. The resulting solution was sonicated for 4 min
to obtain better particle dispersion. A drop of the dis-
persed solution was then deposited onto a copper grid
and dried overnight at room temperature. The binding of
GOX onto the magnetic nanoparticles was investigated
using FTIR spectroscopy. Samples for FTIR analysis were
prepared in phosphate buffer pH 7.4. The activity of
bound GOX was determined by measuring the initial rate
of formation of hydrogen peroxide at a given temperature
following the formation of a red quinoneimine dye. The
principle of enzymatic determination of the activity of
glucose oxidase is described as follows: Glucose is oxi-
dized by glucose oxidase to gluconate and hydrogen per-
oxide. Phenol + 4-AAP, in the presence of peroxidase
(POX), produces a quinoneimine dye that is measured at
500 nm using a Beckman Du Spectrometer to provide an
absorbance that is proportional to the concentration of
glucose in the sample. The reaction is described as
follows:
The activity of glucose oxidase was measured as follows.
An assay mixture was prepared by mixing 500 U of horse-
radish peroxidase, 0.015 mmol of 4-aminoantipyrine (4-
AAP), 0.025 mmol of phenol and 5 mmol of glucose in 50
mL of phosphate buffer solution (0.05 M. pH 7.4) to
result in a glucose concentration of 0.1 M. To start the
enzymatic reaction, 2 mL of the assay solution was added
to 15 mL centrifuge test tubes containing GOX-Fe3O4 and
mixed by vortex. A solution of free GOX of the same molar
concentration was used to evaluate the activity of the free
enzyme for comparison. The solution was incubated at
various temperatures (37–80°C) at specific intervals of
time (30 min) and the supernatant was separated from
GOX-Fe3O4 using a magnetic separator. 10 µL aliquots of
the supernatant were then taken for determining the
Description of GOX attachment procedures Figure 1
Description of GOX attachment procedures. (I) procedure 
employed for GOX-Fe3O4 I attachment, (II) thiophene func-
tionalization and the acetylation of particles for GOX-Fe3O4 
II attachment.
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concentration of hydrogen peroxide following the proce-
dure by Trinder [18]. The activity of the enzyme can be cal-
culated using the following equation:
Where ABS sample denotes the absorbance of the sample,
ABS Std is the absorbance of the standard solution, and C
the concentration of glucose in the sample.
The effect of temperature on the free GOX, GOX-Fe3O4 I
and GOX-Fe3O4 II was estimated by determining the con-
centration of glucose in the sample at various tempera-
tures. A solution of the assay mixture was added to the
various centrifuge test tubes containing bound or free
enzymes. The samples were stored in a water bath at spe-
cific temperatures (37, 50, 60, 70 and 80°C) and the
absorbance was monitored at fixed time intervals to deter-
mine the glucose content. The effect of pH on GOX was
monitored by measuring the initial rate of glucose oxida-
tion by glucose oxidase in different phosphate and car-
bonate buffer solutions of pH (5–10) at 25°C.
The thermal stability of free GOX, GOX-Fe3O4 I, and
GOX-Fe3O4 II were determined by measuring the residual
activity of the enzyme at 25°C, after being exposed to dif-
ferent temperatures (37–80°C) in phosphate buffer (0.05
M, pH 7.4) for 30 min. Aliquots of the reacting solutions
were taken at periodic intervals (every 30 min for 6 h) and
assayed for enzymatic activity as described above. The
first-order inactivation rate constant, k  was calculated
from the equation:
ln A = ln A0 - kt   (5)
where A0 is the initial activity, A is the activity after time t
(min) and k is the reaction constant.
The storage stability was examined by measuring the
change in the concentration of glucose at room
temperature at different time intervals (4 days). Test tubes
with samples of GOX-Fe3O4 I, GOX-Fe3O4 II, or free GOX
solutions were stored at 25°C in phosphate buffer (0.05
M. pH 7.4) for 33 days. Thereafter, 3 mL of the assay solu-
tion was added, and the residual activity of GOX was
assayed.
The kinetic parameters of free GOX, GOX-Fe3O4 I and
GOX-Fe3O4 II, Km and Vmax were determined by measuring
the initial rates of glucose oxidation (0.2–1 mM) by glu-
cose oxidase (0.25 mg/mL) in phosphate buffer (pH 7.4)
at 25°C.
Results and discussion
Synthesis of magnetic nanoparticles with equivalent
amounts of ferric and ferrous chlorides resulted in 66% of
magnetic nanoparticles I and 73% of magnetic nanoparti-
cles II. These yields suggested that the synthesis using
NaOH is more advantageous for large scale production of
magnetic nanoparticles. "Bare" Fe3O4 I and Fe3O4 II, and
their GOX bound counterparts shown in the TEM micro-
graphs in Figures (2A, B, C and 2D), respectively reveal
that the particles are fine and spherical. The sizes of the
particles of each sample were evaluated from 2 different
TEM images. The diameter was in the range between 9 and
13 nm. The coefficient of variation between different
measurements was less than 7%. There was no significant
change in the size of the 'bare" particles and GOX bound
particles. However, signs of agglomeration of the particles
were visible in the samples. The agglomerates were not
considered in the examination of the size distribution of
the magnetic particles because of the assumption that
agglomerated particles do not describe the original size of
the particles. Figure 3 shows the distribution of the parti-
cles sizes. Fe3O4nanoparticles 14.5 mg/mL corresponding
to GOX/Fe3O4 weight ratios of 0.2 was used for the bind-
ing process. The amount of unbound enzyme was deter-
mined by assaying the protein content in the supernatant.
The amount of enzymes bound to the magnetic nanopar-
ticles in each binding procedure is given in table 1. Aver-
age binding efficiencies of 38.4 units/mg particles for
GOX-Fe3O4 I and 27.6 units/mg particles for GOX-Fe3O4
II were noted. The overall percentage of binding efficiency
was between 94 and 100% for GOX-Fe3O4 I and 66 to
72% for GOX-Fe3O4 II. These results show that the bind-
ing was successful in both cases, particularly with Fe3O4 I
which uses the carbodiimide activation. The percentage of
binding of GOX to Fe3O4II was significant but still below
the level obtained through carbodiimide activation with
the Fe3O4 I. However, despite the difference in the level of
GOX bound, the two procedures adopted were successful.
The FTIR spectra of magnetic Fe3O4 I, Fe3O4 II, GOX-Fe3O4
I and GOX-Fe3O4 II are shown in Figure 4(A, B, C, D),
respectively. The characteristic bands of proteins at 1541
and 1645 cm-1 assigned to amide I and amide II, respec-
tively were visible in the spectra of GOX-Fe3O4 I and GOX-
Fe3O4 II. These peaks are associated with two sharp peaks
in the region 1420-1300 cm-1  typical of carboxylate
groups, from the enzyme. A weak peak at 1900 cm-1
appeared in the spectra of GOX-Fe3O4 I and GOX-Fe3O4 II
and could be assigned to the C-O bonds in the enzyme
molecule. These peaks were absent in the spectra of Fe3O4
I and Fe3O4 II. In the 1100-1000 cm-1 region in all spectra
appeared a characteristic adsorption spectra typical to
phosphate ion that can be assigned to the phosphate
buffer used in the samples preparation. The occurrence of
negative peaks in the spectra of Fe3O4 I, and GOX-Fe3O4 II
Concentration of glucose (mg/L) =
ABS Sample
ABS Std
Co fS t d
()
()
*( (mg/L)    4 ()BioMagnetic Research and Technology 2005, 3:1 http://www.biomagres.com/content/3/1/1
Page 5 of 10
(page number not for citation purposes)
is possibly due to the reduced amount of phosphate in
comparison to the amount of phosphate used to back-
ground subtraction. The characteristic peaks of proteins
found in the spectra of GOX-Fe3O4 I and GOX-Fe3O4 II
were not visible in the spectra of Fe3O4 I and Fe3O4 II,
indicating enzyme attachment onto the particles. The
amino groups on the surface of the particles resulted from
the use of concentrated ammonia solution during the co-
precipitation of Fe2+ and Fe3+ as demonstrated by [5] and
[19].
Transmission electron micrographs of Fe3O4 magnetic nanoparticles I (A), Fe3O4 magnetic nanoparticles II (B), GOX-Fe3O4 I  (C), and GOX-Fe3O4 II (D) Figure 2
Transmission electron micrographs of Fe3O4 magnetic nanoparticles I (A), Fe3O4 magnetic nanoparticles II (B), GOX-Fe3O4 I 
(C), and GOX-Fe3O4 II (D).
                       A                                                                B 
                      C                                                                     D
100 nm            BioMagnetic Research and Technology 2005, 3:1 http://www.biomagres.com/content/3/1/1
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The most important aspect of this study is related to the
retention of biocatalytical activity of GOX after binding to
magnetic nanoparticles. The amount of bound GOX was
estimated using the UV-vis spectrophotometer and the
catalytic activity of free and bound GOX was compared.
Kinetic parameters (Vm and Km) were estimated from the
double reciprocal plots of the initial rates of glucose oxi-
dation by GOX. The double reciprocal plots are presented
in Figure 5. The Michaelis-Menten constants Vmax and Km
for GOX are shown in Table 2. Vmax of free GOX, GOX-
Fe3O4 I and GOX-Fe3O4 II were 0.731, 0.803, and 0766
µmol/min mL and, the corresponding Km values were,
0.383, 0.208, and 0.237 mM, respectively. The Vmax value
of GOX immobilized on magnetic nanoparticles (I and II)
was higher than that of the free enzyme. The highest Vmax
was obtained with GOX-nanoparticles I. Since a low Km
indicates a high degree of affinity of the enzyme to sub-
strate [5], calculations showed that the affinity of the
enzyme to the substrate increased in the order of free
GOX, GOX-Fe3O4 II and GOD-Fe3O4 I, respectively. The
high affinity of the enzyme to the substrate may be
explained by a favorable change in the structural organi-
zation of the enzyme due to the immobilization proce-
dure [20]. Consequently, the active sites of the enzymes
Distribution of particles on the electron micrographs of  Fe3O4 magnetic nanoparticles I and GOX-Fe3O4 I (A), and  Fe3O4 magnetic nanoparticles II and GOX-Fe3O4 II (B) Figure 3
Distribution of particles on the electron micrographs of 
Fe3O4 magnetic nanoparticles I and GOX-Fe3O4 I (A), and 
Fe3O4 magnetic nanoparticles II and GOX-Fe3O4 II (B).
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Table 1: Summary of binding efficiencies of enzyme-
functionalized systems (n = 9).
Bound enzymes (units/mg 
nanoparticles)
GOX-Fe3O4 I 38.4 ± 0.8
GOX-Fe3O4 II 27.6 ± 0.6
FTIR spectra of Fe3O4 magnetic nanoparticles I (A) and  Fe3O4 magnetic nanoparticles II (B), GOX-Fe3O4 I (C), and  GOX-Fe3O4 II (D) Figure 4
FTIR spectra of Fe3O4 magnetic nanoparticles I (A) and 
Fe3O4 magnetic nanoparticles II (B), GOX-Fe3O4 I (C), and 
GOX-Fe3O4 II (D).
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could be more readily available for enzymatic
interactions.
The effect of pH on the activities of the free and bound
GOX was investigated in the pH range of 5–10 at 25°C
(Figure 6). Each data point was the average of two meas-
urements. The coefficient of variation between
measurements was between 2 and 5%. In the pH range
between 6 and 7.4, the enzyme activity increased in all the
systems. However, the enzyme activity was higher in
GOX-Fe3O4 I than in GOX-Fe3O4 II and free GOX. The
activity reached 100% at pH 7.4, and decreased above this
pH value to 43% for GOX-Fe3O4 I, and to 26% for GOX-
Fe3O4 II and 9% for the free GOX at pH 10. The free GOX
experienced a more severe loss in activity, while GOX-
Fe3O4 I retained greater activity as the pH increased. In this
system, the binding process occurred directly upon activa-
tion of the particle surface using carbodiimide, while the
binding of GOX-Fe3O4 II involved a C = N bond formed
on the acetylated thiophene. It can be argued that the
direct binding between the protein and the amino bond
in the former case exhibited a greater resistance to a
medium with higher alkalinity. This medium appeared
even more constraining to the free enzyme and placed the
enzyme in an electrostatic state that might affect the
activity.
The effect of temperature on the activity of free GOX was
examined by measuring its relative activity when stored at
various temperatures. Figure 7a and 7b shows the effect of
temperature on GOX-Fe3O4 I and GOX-Fe3O4 II at various
temperatures. Each data point represents the average of
duplicate measurements (coefficient of variation was less
than 6 %). It can be observed that at 37°C, the enzyme
retained its activity for about 80 minutes before showing
a slight decrease. At 50, 60, 70 and 80°C the activity
decreased as the temperature increased in both systems. In
GOX- Fe3O4, the remaining activity was 23% at 50°C and
15% at 60°C after 270 min. For this time period and dura-
tion, the remaining activities were 9% and 0%, respec-
tively for GOX-Fe3O4 II. A similar trend was observed at 70
and 80°C with a more drastic loss of activity from the
GOX-Fe3O4 II protocol. Loss of activity occurred more rap-
idly in GOX-Fe3O4  II indicating that direct binding
through carbodiimide activation provides a greater ther-
mal stability to GOX. The effect of temperature on the
activities of free, GOX-Fe3O4 I, and GOX-Fe3O4 II at pH
7.4 are presented in the Arrhenius plots (Figure 8). The
activation energies were calculated as 1.4, 0.9, and 1.1 kJ/
Double reciprocal plots of the initial rates of free GOX (■ ),  GOX-Fe3O4 I (▲ ) and GOX-Fe3O4 II (● ) at pH 7 Figure 5
Double reciprocal plots of the initial rates of free GOX (■ ), 
GOX-Fe3O4 I (▲ ) and GOX-Fe3O4 II (● ) at pH 7.4, from 
experimental data.
Table 2: Kinetic parameters of free GOX, GOX-Fe3O4 I, and 
GOX-Fe3O4 II determined from the double reciprocal plots.
Vmax (µmol/min mL) Km (mM)
Free GOD 0.731 0.383
GOD-Fe3O4 I 0.803 0.208
GOD-Fe3O4 II 0.766 0.237
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mol for free-GOX, GOX-Fe3O4  I, and GOX-Fe3O4  II,
respectively. These results show that the unbound enzyme
has the highest activation energy, while GOX-Fe3O4 I had
the lowest. The low activation energy of GOX associated
with binding to magnetic nanoparticles suggests that the
energy requirement on the surfaces of the nanoparticles
for enzymatic activity is reduced. Table 3 shows the inac-
tivation rates constants (k) at 50, 60 70, and 80°C. The
rate constants increased with increasing temperature in
the order GOX-Fe3O4 I, GOX-Fe3O4 II and free GOX. Here
again, binding GOX to magnetic nanoparticles mini-
mized structural denaturation due to heat treatment. Cov-
alent binding was expected to provide the enzyme with
the protection against structural denaturation due to the
unfavorable solvent-protein interactions, and thus result
in activation effect [21], a possible reason for a better
activity of the bound enzyme compared with the free
enzyme after heat treatment. GOX-Fe3O4 II had a lower
stability at higher temperatures compared to GOX-Fe3O4
I. The reason for this difference could reside in the stabil-
ity of the binding, since the binding methods are so far the
major difference between these systems. Indeed with
GOX-Fe3O4 I, the binding of the enzyme occurred through
the amino groups on the surfaces of the particles and the
carboxylic groups of proteins in the enzymes [5] which is
a natural way for protein binding, while in the case of
GOX-Fe3O4 II the N atom to which the enzyme is attached
shared a double bond with the carbon atom which is less
stable than the amide bond.
Loss of storage stability is a major concern in enzyme pres-
ervation. The storage stability of the enzyme was exam-
ined for 33 days. Figure 9 shows the storage stabilities of
free GOX, GOX-Fe3O4 I, and GOX-Fe3O4 II at 25°C at pH
7.4. Each data point was the average of duplicate
Effect of temperature on the activity of GOX-Fe3O4 I (A) and  GOX-Fe3O4 II (B) at pH 7.4 Figure 7
Effect of temperature on the activity of GOX-Fe3O4 I (A) and 
GOX-Fe3O4 II (B) at pH 7.4. The samples were stored at 37, 
50, 60, 70 and 80°C for 30 min and the activities were meas-
ured at 25°C.
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measurements (coefficient of variation of the measure-
ments was between 1 and 5%). The activity decreased with
time in all the systems. Total loss of activity was observed
after 20 days for the free GOX and 28 days for GOX-Fe3O4
II while GOX-Fe3O4 I retained 26% activity after 33 days
of storage under identical conditions. The stability of the
enzyme was found to improve upon binding to the mag-
netic nanoparticles but the most significant improvement
in stability was observed for the GOX-Fe3O4 I nanoparticle
complex. The fixation on the surface of the magnetic nan-
oparticles has been a tangible argument supporting the
prevention of auto-digestion of the enzyme and lysis, and
the subsequent conservation of its activity [4]. This argu-
ment supports our results and justifies the long term sta-
bility of GOX-nanoparticles I and GOX-nanoparticles II
over the free GOX. The efficiency of binding of GOX via
carbodiimide activation over the binding by thiophene
acetylation may be attributed to the potential of carbodi-
imide to activate the carboxylic acid side chains partially
buried at the surface or in active sites of the enzyme, as
well as the amino groups on the nanoparticles, favoring
the formation and the stability of the amide bond [22].
This may explain why the amount of bound enzymes is
higher in the binding via carbodiimide than with the thi-
ophene acetylation. Furthermore, carbodiimide might
cause cross-linking of the enzyme providing a better
stability to its quaternary structure [23] and a subsequent
improvement in stability.
Conclusion
Magnetic nanoparticles were synthesized by thermal co-
precipitation of ferric and ferrous chlorides using two dif-
ferent base solutions. GOX was bound to the particles by
direct attachment via carbodiimide activation and
chemically via covalent attachment onto thiophene
acetylated magnetic nanoparticles. Confirmation of the
binding was demonstrated by FTIR spectroscopy and the
sizes of the particles were characterized by TEM. The direct
binding of GOX via carbodiimide activation was more
effective and resulted in binding efficiency in the range
between 94–100% while the binding efficiency was only
between 66–72% for the GOX-Fe3O4 II complex. Kinetic
and stability studies showed that the enzyme activity was
more preserved upon binding onto the nanoparticles
when the complex was subjected to thermal and pH vari-
ations. This study shows that binding onto magnetic nan-
oparticles can allow the enzyme to acquire the
conformational and structural arrangement for a better
activity and stability, and suggests that binding of enzyme
onto magnetic nanoparticles via carbodiimide activation
was efficient for creating bioconjugates for a variety of
applications in health and food safety.
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Table 3: Inactivation rate constants (k) of the free-GOX, GOX-Fe3O4 I, and GOX-Fe3O4II at various temperatures.
Temperature (°C) Free-GOX k (min-1)G O X - F e 3O4 I k (min-1)G O X - F e 3O4 II k (min-1)
50 3.42. 10-2 7.10.10-4 2.87.10-3
60 9.36.10-2 1.49.10-3 3.50.10-2
70 2.81.10-1 6.24.10-2 1.92.10-2
80 9.3210-1 4.52.10-2 5.46.10-1
Storage stability of free GOX (■ ), GOX-Fe3O4 I (▲ ), and  GOX-Fe3O4 II (● ) measured at a pH of 7.4 at 25°C Figure 9
Storage stability of free GOX (■ ), GOX-Fe3O4 I (▲ ), and 
GOX-Fe3O4 II (● ) measured at a pH of 7.4 at 25°C.
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